Robert Stephen Kauffman

Person

Chestnut Hill, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor...
- Patent number 12,161,674
- Issue date Dec 10, 2024
- Vertex Pharmaceuticals Incorporated
- Ewelina Morawa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950...
- Patent number 8,871,812
- Issue date Oct 28, 2014
- Robert S. Kauffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor...
- Publication number 20250041349
- Publication date Feb 6, 2025
- VERTEX PHARMACEUTICALS INCORPORATED
- Ewelina Morawa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CRISPR-CAS9 MODIFIED CD34+ HUMAN HEMATOPOIETIC STEM AND PROGENITOR...
- Publication number 20200384033
- Publication date Dec 10, 2020
- VERTEX PHARMACEUTICALS INCORPORATED
- Ewelina Morawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950...
- Publication number 20130101554
- Publication date Apr 25, 2013
- Vertex Pharmaceutical Incorporated
- ROBERT S. KAUFFMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HCV Combination Therapies Comprising Pegylated Interferon, Ribaviri...
- Publication number 20120039850
- Publication date Feb 16, 2012
- Janssen Pharmaceutica N.V.
- Lindsay McNair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Regimen Comprising PEG-Interferon, Ribavirin and VX-950...
- Publication number 20110236351
- Publication date Sep 29, 2011
- Vertex Pharmaceuticals Incorporated.
- Robert S. Kauffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TELAPREVIR DOSING REGIMEN
- Publication number 20110165119
- Publication date Jul 7, 2011
- Maria Gloria Beumont
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dose forms comprising VX-950 and their dosage regimen
- Publication number 20100189688
- Publication date Jul 29, 2010
- Vertex Pharmaceuticals Incorporated.
- Lindsay McNair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for treating rheumatoid arthritis
- Publication number 20070225339
- Publication date Sep 27, 2007
- Ramon Mohanlal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for HCV infection
- Publication number 20050112093
- Publication date May 26, 2005
- Ene Ette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Robert Stephen Kauffman

Person

Patents Grantslast 30 patents

CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor...

Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950...

Patents Applicationslast 30 patents

CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor...

CRISPR-CAS9 MODIFIED CD34+ HUMAN HEMATOPOIETIC STEM AND PROGENITOR...

THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950...

HCV Combination Therapies Comprising Pegylated Interferon, Ribaviri...

Therapeutic Regimen Comprising PEG-Interferon, Ribavirin and VX-950...

TELAPREVIR DOSING REGIMEN

Dose forms comprising VX-950 and their dosage regimen

Compositions and methods for treating rheumatoid arthritis

Combination therapy for HCV infection